✦ LIBER ✦

Phase II study of weekly irinotecan (CPT-11) as second-line treatment of patients with advanced colorectal cancer

✍ Scribed by J. Cassinello; P. López-Alvarez; A. Martínez-Guisado; M. Valladares; G. Huidobro; R. López; U. Bohn; I. Sevilla; P. Ballesteros; M. Jorge; R. Pérez-Carrión; J. L. Fernández; J. Dorta

Book ID: 111640902
Publisher: Springer US
Year: 2003
Tongue: English
Weight: 106 KB
Volume: 20
Category: Article
ISSN: 1357-0560
DOI: 10.1385/mo:20:1:37

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

237 A phase I study of irinotecan (CPT-1

237 A phase I study of irinotecan (CPT-11) and capecitabina (XL) as second line treatment in advanced colorectal cancer

✍ P. Garcia-Alfonso; A. Munoz; M. Méndez; S. Garcia-Adrian; P. Lopez-Criado; R. Al 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Phase I trial of weekly irinotecan combi

Phase I trial of weekly irinotecan combined with UFT as second-line treatment for advanced colorectal cancer

✍ V Alonso; P Escudero; M Zorrilla; M.D Isla; A Herrero; J.I Mayordomo; J Martinez 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 105 KB

A phase II study of weekly irinotecan (C

A phase II study of weekly irinotecan (CPT-11) and oral uracil and ftorafur (UFT) plus folinic acid (FA) as first line treatment in advanced colorectal cancer (CRC)

✍ Cruz, J.; Mendez, M.; Alfonso, P.; Gonzalez, E.; Pujol, E.; Castañon, C.; Cerezu 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Phase I study of weekly CPT-11 (irinotec

Phase I study of weekly CPT-11 (irinotecan)/docetaxel in patients with advanced solid tumors

✍ Font, A; Sanchez, J.M; Rosell, R; Taron, M; Martinez, E; Guillot, M; Manzano, J. 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Cisplatin and irinotecan (CPT-11) as sec

Cisplatin and irinotecan (CPT-11) as second-line treatment in patients with advanced non-small cell lung cancer

✍ Kakolyris, S; Kouroussis, Ch; Souglakos, J; Agelaki, S; Kalbakis, K; Vardakis, N 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 79 KB

A multicenter phase II study of irinotec

A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancer

✍ JuanJosé Reina; Jorge Aparicio; Javier Salvador; JoséMaríaPuerto Pica; Antonio R 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 192 KB